Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

How many kinases are druggable? A review of our current understanding
Brian Anderson, Peter Rosston, Han Wee Ong, et al.
Biochemical Journal (2023) Vol. 480, Iss. 16, pp. 1331-1363
Open Access | Times Cited: 21

Showing 21 citing articles:

The IUPHAR/BPS Guide to PHARMACOLOGY in 2024
Simon D Harding, Jane F Armstrong, Elena Faccenda, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1438-D1449
Open Access | Times Cited: 113
A review of recent advances in anticancer activity and SAR of pyrazole derivatives
Heba A. Hofny, Mamdouh F. A. Mohamed, Heba A. Hassan, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 3
Closed Access
Evaluation of DNA encoded library and machine learning model combinations for hit discovery
Sumaiya Iqbal, Wei Jiang, Eric R. Hansen, et al.
npj Drug Discovery. (2025) Vol. 2, Iss. 1
Open Access
Data-oriented protein kinase drug discovery
Elena Xerxa, Jürgen Bajorath
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116413-116413
Open Access | Times Cited: 4
KinomeMETA: a web platform for kinome-wide polypharmacology profiling with meta-learning
Zhaojun Li, Ning Qu, Jingyi Zhou, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. W1, pp. W489-W497
Open Access | Times Cited: 4
A Medicinal Chemistry Perspective on Protein Tyrosine Phosphatase Nonreceptor Type 2 in Tumor Immunology
Qi Huang, Linghao Hu, Hao Chen, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
DrugDomain: The evolutionary context of drugs and small molecules bound to domains
Kirill E. Medvedev, R. Dustin Schaeffer, Nick V. Grishin
Protein Science (2024) Vol. 33, Iss. 8
Open Access | Times Cited: 3
TKL family kinases in Human Apicomplexan pathogens
Dima Hajj Ali, Rajshekhar Y. Gaji
Molecular and Biochemical Parasitology (2024) Vol. 259, pp. 111628-111628
Open Access | Times Cited: 1
Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson’s disease: a patent review of the literature to date
Margaux Morez, Antonio Jesús Lara Ordóñez, Patricia Melnyk, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 9, pp. 773-788
Closed Access | Times Cited: 1
Elucidating the Selective Mechanism of Drugs Targeting Cyclin-Dependent Kinases with Integrated MetaD-US Simulation
Lingling Wang, Shu Li, Sutong Xiang, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 17, pp. 6899-6911
Closed Access | Times Cited: 1
Assessing Darkness of the Human Kinome from a Medicinal Chemistry Perspective
Selina Voßen, Elena Xerxa, Jürgen Bajorath
(2024)
Open Access | Times Cited: 1
The expanding landscape of canonical and non-canonical protein phosphorylation
Thibault Houlès, Sang-Oh Yoon, Philippe P. Roux
Trends in Biochemical Sciences (2024) Vol. 49, Iss. 11, pp. 986-999
Closed Access | Times Cited: 1
Activating Invasion and Metastasis in Small Cell Lung Cancer: Role of the Tumour Immune Microenvironment and Mechanisms of Vasculogenesis, Epithelial‐Mesenchymal Transition, Cell Migration, and Organ Tropism
Carl He
Cancer Reports (2024) Vol. 7, Iss. 10
Open Access | Times Cited: 1
Navigating the Maze of Kinases: CaMK-like Family Protein Kinases and Their Role in Atherosclerosis
Jules T. J. Teuwen, Emiel P. C. van der Vorst, Sanne L. Maas
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6213-6213
Open Access
Screening of a kinase inhibitor library identified novel targetable kinase pathways in triple-negative breast cancer
Caroline H. Rinderle, C. Baker, C Lagarde, et al.
Anti-Cancer Drugs (2024) Vol. 36, Iss. 1, pp. 39-48
Open Access
Assessing Darkness of the Human Kinome from a Medicinal Chemistry Perspective
Selina Voßen, Elena Xerxa, Jürgen Bajorath
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 19, pp. 17919-17928
Closed Access
Pharmacological inhibition of the MAP2K7 kinase in human disease
H. Daniel Lacorazza
Frontiers in Oncology (2024) Vol. 14
Open Access
Probing the Protein Kinases' Cysteinome by Covalent Fragments
Guiqun Wang, Nico J. Seidler, Sandra Röhm, et al.
Angewandte Chemie International Edition (2024)
Closed Access
Probing the Protein Kinases' Cysteinome by Covalent Fragments
Guiqun Wang, Nico J. Seidler, Sandra Röhm, et al.
Angewandte Chemie (2024)
Closed Access
Another decade of antimalarial drug discovery: New targets, tools and molecules
John G. Woodland, André Horatscheck, Candice Soares de Melo, et al.
Progress in medicinal chemistry (2024), pp. 161-234
Closed Access
Advancements in Rational Multi‐Targeted Drug Discovery
Balaguru Ravikumar, Anna Cichońska, Navriti Sahni, et al.
(2024), pp. 109-125
Closed Access
Page 1

Scroll to top